BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices MARLBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ -- Data ...

LONDON (Reuters) - British pharmaceutical firm BTG said on Monday its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment periods ...

The KNOCOUT PE registry was established to measure institutional adoption of a lower dose and lower-duration thrombolysis protocol for the EKOS system. The data confirmed the safety and efficacy of ...

A new study using Boston Scientific's EkoSonic endovascular system (EKOS) aims to address current gaps in clinical guidelines for the treatment of pulmonary embolism. The first-of-its-kind trial will ...

CORPUS CHRISTI, Texas — A local procedure is now available here in Corpus Christi for high-risk patients with pulmonary embolism. Pulmonary embolism is a blockage in one of the pulmonary arteries in ...

Please provide your email address to receive an email when new articles are posted on . As catheter-directed therapies have advanced in recent years, they are becoming a critical part of the strategy ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today the EKOS EkoSonic ® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The ...

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices Each year, approximately 350,000 patients in the United ...